City

Bethesda (2)

San Francisco (1)

Overall Status

Completed (2)

Active, not recruiting (1)

No longer available (1)

Phase

n/a (1)

phase 2/phase 3 (1)

Sponsor

Christopher Dvorak (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

University of Sao Paulo (1)

Collaborator

AstraZeneca (1)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (1)

InCor Heart Institute (1)

Intervention

benralizumab (1)

cd34+ enriched, t cell depleted donor stem cell product (1)

filtering group lg-6, pall biomedical products (1)

placebo (1)

Study Documents

Intervention Type

biological (1)

device (1)

drug (1)

other (1)

Funder Type

NIH (2)

Other (2)

Study Type

Interventional (2)

Expanded Access (1)

Observational (1)

leukocyte disorders

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

Active, not recruiting

Has Results

Respiratory System Agents
+4 more

benralizumab
Placebo

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jan 20, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell

No longer available

Acute Lymphoblastic Leukemia
+11 more

CD34+ enriched, T Cell Depleted donor stem cell product

San Francisco, California

University of California, San Francisco

May 25, 2021

Natural History Study for BEN

Completed

Neutropenia
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jun 29, 2020

Systemic Inflammatory Response Syndrome (SIRS), Leukocyte Disorders, Complications Due to Coronary Artery Bypass Graft Trial

Completed

Systemic Inflammatory Response Syndrome (SIRS)
+2 more

Filtering group LG-6, Pall Biomedical Products

(no location specified)

Nov 9, 2011